Diacerein
-
Diacerein
structure -
-
CAS No:
13739-02-1
-
Formula:
C19H12O8
-
Chemical Name:
Diacerein
-
Synonyms:
2-Anthracenecarboxylic acid,4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-;2-Anthroic acid,9,10-dihydro-4,5-dihydroxy-9,10-dioxo-,diacetate;Rhein,diacetate;4,5-Bis(acetyloxy)-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid;1,8-Diacetoxy-3-carboxyanthraquinone;Diacetylrhein;4,5-Diacetylrhein;Diacerhein;Diacerein;4,5-Diacetoxyanthraquinone-2-carboxylic acid;DAR;SF 277;Fisiodar;Artrodar;4,5-Diacetoxy-9,10-dioxoanthracene-2-carboxylic acid;Osteocerein;AC 201;Inflabion
-
Categories:
Active Pharmaceutical Ingredients > Drugs Influencing Immune Function
-
CAS No:
Description
Yellow Crystalline SolidDiacerein is a disease-modifying antirheumatic drug (DMARD), reported to beuseful in the treatment of various inflammatory conditions, includingosteoarthritis. It forms water soluble chelates with calcium and copper, actingultimately to reduce the activity of lysosomal enzymes and decrease the formationof rheumatoid factor.Diacerein is a novel interleukin (IL)-1 inhibitor , the chemical name is diacetyl rhein,it is a compound of anthraquinones, the product can i
4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic acid is an anthraquinone.|Diacerein is a prodrug which is metabolized to rhein. It is currently approved in France for the treatment of osteoarthritis although the use of diacerein is restricted due to the side effects including sevre diarrhea. Diacerein is under investigation for the treatment of Insulin Resistance, Diabetes Mellitus (Type 2), and Diabetes-Related Complications.
Diacerein Basic Attributes
368.29400
368.29
237-310-2
4HU6J11EL5
758147
DTXSID4045636
M - Musculo-skeletal system
2918990090
Characteristics
124.04000
1.9
1.491±0.06 g/cm3(Predicted)
217.5 °C
631.5±55.0 °C(Predicted)
231.8±25.0 °C
1.634
Safety Information
NONH for all modes of transport
3
36/37/38
26-36
CB8781000
Xi
P305 + P351 + P338
H315-H319-H335
|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 59 companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Toxicity
Rhein [DB13174] has an oral LD50 of >5000mg/kg in mice. This is equivalent to a diacerein dose of >6476mg/kg.
99% of rhein is bound to plasma proteins.
Drug Information
For the treatment of osteoarthritis affecting the hip or knee.
Decreases inflammation and cartilage destruction and also corrects altered osteoblast acitivity.
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
Bioavailability of 50-60%. Entirely converted to the active metabolite rhein [DB13174] before reaching systemic circulation.|37% excreted in urine and 53% in feces as estimated in rats.|15-60L.|Total CL is 1.5L/h and renal CL is 0.1L/h.
Entirely converted to rhien [DB13174] through double deacetylation before reaching systemic circulation. Rhein [DB13174] is further metabolized to rhein glucuronide and rhein sulfate.
4-10h.
Diacerein's active metabolite rhein [DB13174] reduces cartilage destruction by decreasing expression of matrix metalloproteinase (MMP)-1 and -3 as well as upregulating tissue inhibitor of matrix metalloproteinases which serve to reduce the activity of several MMPs. The anti-inflammatory action of rhein reduces the level of interleukin-1beta activity which plays a large role in reduction of extracellular matrix production, MMP activity, and continued inflammation. Rhein reduces abnormal osteoblast synthetic activity through an unknown mechanism.
diacerein
Diacerein Use and Manufacturing
It is widely used in new liquid crystal polymers, high-strength fibers and engineering plastics with excellent performance; this product is an important inhibitor of osteoarthritis IL-1. Natural antioxidants, have the effects of delaying aging, enhancing immunity, clearing sub-health conditions, restoring physical fitness, improving energy and body immunity; an interleukin-1β inhibitor, a slow-acting anthraquinone compound.
Human drugs -> Rare disease (orphan)|Pharmaceuticals
Computed Properties
Molecular Weight:368.3
XLogP3:1.9
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:8
Rotatable Bond Count:5
Exact Mass:368.05321734
Monoisotopic Mass:368.05321734
Topological Polar Surface Area:124
Heavy Atom Count:27
Complexity:683
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
No specific pharmacological effects mentioned
Registered Holders
-
Hangzhou Whiteoak MEDICAL Consult Co., Ltd.
Active
China
-
Harmony PharmaTech (Nanjing) Co., Ltd.
Active
China
-
Cang Zhou Wisdom Pharma Co., Ltd.
Active
China
Recommended Suppliers of Diacerein
-
CN
3 YRS
Business licensedTrader Supplier of Apigenin,PQQ,NMNH -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Minoxidil,Paracetamol,Diclofenac sodium,fenbendazole,Ivermectin -
CN
10 YRS
Business licensed Certified factoryManufactory Supplier of natural extracts -
CN
3 YRS
Business licensedTrader Supplier of olive leaf extract,ginger extract,ginseng extract,Black garlic extract,Echinacea purpurea extract,Horse Chestnut Extract,Pueraria extract,Andrographis Extract,citrus aurantium extract,quercetin,Rutin,chlorogenic acid,Curcumin,Apigenin -
CN
2 YRS
Business licensedTrader Supplier of Peptide,API,HCG,Amino Acids,Plant Extract,VitaminInquiryCAS No.: 13739-02-1Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
N-[N-Acetyl-4-O-[2-(acetylamino)-2-deoxy-β-D-glucopyranosyl]-1,6-anhydro-β-muramoyl]-L-alanyl-D-γ-glutamyl-(6R)-6-carboxy-L-lysyl-D-alanine
94102-64-4
-
Everolimus
159351-69-6
-
Isoprinosine
36703-88-5
-
Anti-CD3 Formula
140608-64-6
-
TNFR-Fc fusion protein Formula
185243-69-0
-
RAT IL-2 Formula
95568-40-4
-
Mizoribine Structure
50924-49-7
-
Rapamycin Structure
53123-88-9
-
What is Melatonin
73-31-4
-
What is Imiquimod
99011-02-6